Chin-Chou Wang

Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Lung Adenocarcinomas with G719X/L861Q/S768I Mutations

Chao‐Hua Chiu, Cheng‐Ta Yang, Jin‐Yuan Shih et al. · Journal of Thoracic Oncology · 2015 · 245 citations

Medicine, Oncology, Pharmacology +14

Safety, Efficacy, and Pharmacokinetics of Almonertinib (HS-10296) in Pretreated Patients With EGFR-Mutated Advanced NSCLC: A Multicenter, Open-label, Phase 1 Trial

James Chih‐Hsin Yang, D. Ross Camidge, Cheng‐Ta Yang et al. · Journal of Thoracic Oncology · 2020 · 156 citations · Full text

Pharmacy, Clinical Pharmacokinetics, Pharmacokinetics +12

COPD in Taiwan: a National Epidemiology Survey

Chong‐Jen Yu, Shih-Lung Cheng, Ming-Cheng Chan et al. · International Journal of COPD · 2015 · 79 citations · Full text

Medicine, Chronic Disease Control, Clinical Epidemiology +13

Whole Genome DNA Methylation Analysis of Obstructive Sleep Apnea:<i>IL1R2,</i><i>NPR2</i>,<i>AR</i>,<i>SP140</i>Methylation and Clinical Phenotype

Yung‐Che Chen, Ting-Wen Chen, Mao-Chang Su et al. · SLEEP · 2016 · 55 citations · Full text

Medicine, Genetics, Molecular Biology +17

An Observational Study of Acquired EGFR T790M-Dependent Resistance to EGFR-TKI Treatment in Lung Adenocarcinoma Patients in Taiwan

Shang-Gin Wu, Chi‐Lu Chiang, Chien-Ying Liu et al. · Frontiers in Oncology · 2020 · 35 citations · Full text

Medicine, Oncology, Pharmacology +16